Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

NCT01074632 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder

Interventions

DRUG: Lurasidone HCl

Sponsor

Sumitomo Pharma America, Inc.